Koleka Mlisana

Timing of ART Initiation With Treatment Policy Changes in South Africa: A Cohort Study.

Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in <i>Neisseria gonorrhoeae</i>

Consequences of <i>rpoB</i> mutations missed by the GenoType MTBDR<i>plus</i> assay in a programmatic setting in South Africa.

Tuberculosis testing patterns in South Africa to identify groups that would benefit from increased investigation

Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa

Sexually transmitted infection screening to prevent adverse birth and newborn outcomes: study protocol for a randomized-controlled hybrid-effectiveness trial

Cohort profile: the South African National Health Laboratory Service (NHLS) National HIV Cohort

The role of emergent champions in policy implementation for decentralised drug-resistant tuberculosis care in South Africa

Assessment of Antibiotic Resistance and Efflux Pump Gene Expression in Neisseria Gonorrhoeae Isolates from South Africa by Quantitative Real-Time PCR and Regression Analysis.

High-Resolution Melting Analysis to Detect Antimicrobial Resistance Determinants in South African <i>Neisseria gonorrhoeae</i> Clinical Isolates and Specimens.

Detection of a SARS-CoV-2 variant of concern in South Africa

Detection of a SARS-CoV-2 variant of concern in South Africa.

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Sixteen novel lineages of SARS-CoV-2 in South Africa.

Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa

Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study

Bounding the levels of transmissibility &amp; immune evasion of the Omicron variant in South Africa

COVID-19: lessons and experiences from South Africa's first surge.

Variation in HIV care and treatment outcomes by facility in South Africa, 2011–2015: A cohort study

Variation in HIV care and treatment outcomes by facility in South Africa, 2011-2015: A cohort study.

Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.

'We had to manage what we had on hand, in whatever way we could': adaptive responses in policy for decentralized drug-resistant tuberculosis care in South Africa.

Diverse clinical and social circumstances: developing patient-centred care for DR-TB patients in South Africa

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial.

Genome Sequences of Five Novel Neisseria gonorrhoeae Sequence Types Isolated in KwaZulu-Natal, South Africa.

First genome sequence of Aeromonas hydrophilia novel sequence type 658 strain isolated from livestock in South Africa.

Performance of TaqMan probes for the detection of sexually transmitted infections in South African women.